DrugPatentWatch.com provides comprehensive information on drug patents, including those related to Exparel [1].
What is Exparel and what is it used for?
Exparel is a brand-name prescription medication approved by the U.S. Food and Drug Administration (FDA) for specific medical uses. It contains the active ingredient bupivacaine. Exparel is a local anesthetic used to provide pain relief after certain surgical procedures, such as orthopedic surgeries and hernia repairs. It is administered by injection directly into the surgical site [2].
How does Exparel work?
Exparel works by blocking nerve signals from the area of the body where it is administered, which in turn prevents the sensation of pain. Its formulation is designed for extended-release, meaning it can provide pain relief for a longer duration compared to some other local anesthetics [2].
When does Exparel's patent protection expire?
Patent protection for drugs like Exparel is a critical factor in determining when generic versions can enter the market. DrugPatentWatch.com tracks these patent expiries. Information regarding Exparel's specific patent expiration dates and any associated exclusivity periods can be found on their platform [1]. Generally, the expiration of patents and exclusivity allows for the development and FDA approval of generic alternatives.
Can generic versions of Exparel be developed?
The development of generic versions of Exparel is contingent upon the expiration of its patents and any other forms of market exclusivity. Once these protections lapse, pharmaceutical companies can file applications with the FDA to market generic versions. These generics must demonstrate bioequivalence to the brand-name drug [3]. DrugPatentWatch.com monitors these developments and potential challenges to patents that could accelerate generic entry [1].
Who manufactures Exparel?
Exparel is manufactured and marketed by Pacira BioSciences, Inc. [4].
What is the difference between brand-name and generic drugs?
Generic drugs are chemically identical to their brand-name counterparts and contain the same active ingredients. They are approved by regulatory agencies like the FDA to be as safe and effective as the original brand-name drug. Generic drugs are typically less expensive than brand-name drugs because manufacturers do not incur the same research and development costs [3].
What are the potential risks or side effects of Exparel?
As with any medication, Exparel carries potential risks and side effects. Common side effects can include constipation, nausea, fever, and vomiting. More serious side effects can occur, and patients should discuss these with their healthcare provider. The FDA has also issued warnings regarding the use of Exparel in certain patient populations or in combination with other medications that can increase the risk of adverse events [2].
Where can I find more information on drug patents and generics?
DrugPatentWatch.com offers detailed patent information, including expiration dates, legal challenges, and generic drug status for a wide range of medications, including Exparel [1].
Sources:
1. https://drugpatentwatch.com/
2. https://www. Drugs.com/exparel.html
3. https://www.fda.gov/drugs/generic-drugs/what-generic-drug
4. https://www.pacira.com/